UPDATE 1-Sanofi set to buy Bioverativ for more than $11.5 bln - WSJ
January 21, 2018 at 21:16 PM EST
Jan 21 (Reuters) - Sanofi SA is close to a deal to take over U.S. drug maker Bioverativ Inc for more than $11.5 billion, the Wall Street Journal reported, citing people familiar with the matter.
